
Drug Target Models
GPCR Reporter Cells
Immunotherapy cells
Other Stable Cells
Assay Kits & Reagents
Services
Resources
Company
We Are Pleased to Announce: Global Commercial Licensing Rights for Jurkat E6.1, CHO-K1, HEK293, THP-1 and RAJI Cell Lines Officially Secured.
Explore

Figure 1. Dose-response curves of multiple agonists in Rat CTR&RAMP3 CRE-Luc CHO-K1 (C14) stable cell line
Left panel: CRE-luciferase reporter assay, measuring RLU signal upon agonist stimulation. Right panel: HTRF cAMP assay detecting intracellular cAMP levels. Both assays show distinct agonist potency ranking, confirming functional receptor activity, suitable for agonist screening and pharmacological profiling.

Figure 2. Dose-response curves of GIP in Rat GIPR CRE-Luc HEK293 (C2) stable cell line
Left panel: CRE-luciferase reporter assay, EC50 = 0.0043 nM. Right panel: HTRF cAMP assay, EC50 = 0.0018 nM. The consistent potent agonist response confirms functional Rat GIPR receptor, supporting pharmacological characterization and compound screening.